Relay Therapeutics Company
Relay therapeutics is a developer of an allosteric drug-discovery platform intended to apply computational techniques to protein motion.
Investors
Founded Date:
2016-01-01
Technology:
Biotechnology, Health Care, Therapeutics
Funding Status:
IPO
Total Funding:
1170000000.0
Employee Number:
101-250
Headquarters:
Cambridge, Massachusetts, United States
Last Funding Date:
2022-09-12
Investors Number:
12.0
Last Funding Type:
Post-IPO Equity
Estimated Revenue:
$1M to $10M
Acquisitions Number:
1
Industry:
End-to-End Drug Development